← Leaderboards
Mark A. Murakami
Dana-Farber Cancer Inst
$885,600
Attributed
$885,600
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $177.1K · FY2017–21$200K$150K$100K$50K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$885,600 · 1
By mechanism
K08$885,600 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- David Marc Weinstock$10,844,261
- Wayne A. Marasco$43,896,916
- Martin Sattler$1,793,112
- Sicinska$1,156,101
- Michael J Eck$25,871,961
Others in their field
Other Emerging Leaders on “Clinical Trials”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$245,363,765
- Beth Baseler · Leidos Biomedical Research, Inc.$207,964,226
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$177,411,785
Research focus
Clinical TrialsAcute Promyelocytic LeukemiaCellsAcute LeukemiaAnimal ModelAnimalsArsenicAdultAdult Acute Lymphocytic LeukemiaAcute Lymphocytic LeukemiaBcr/Abl Fusion GeneBcr-Abl Fusion ProteinsBcr-Abl Tyrosine KinaseBench To BedsideBindingBioinformaticsBaseBiological ModelsBiologyBloodCareerCareer DevelopmentCatalytic DomainCode
Grant awards (5)
Overcoming resistance in BCR-ABL-rearranged acute lymphoblastic leukemia$177,120
K08 · FY2021 · CA · contact PI
Overcoming resistance in BCR-ABL-rearranged acute lymphoblastic leukemia$177,120
K08 · FY2020 · CA · contact PI
Overcoming resistance in BCR-ABL-rearranged acute lymphoblastic leukemia$177,120
K08 · FY2019 · CA · contact PI
Overcoming resistance in BCR-ABL-rearranged acute lymphoblastic leukemia$177,120
K08 · FY2018 · CA · contact PI
Overcoming resistance in BCR-ABL-rearranged acute lymphoblastic leukemia$177,120
K08 · FY2017 · CA · contact PI